Background/Aims: We have previously reported that the application of sphingomyelin-based
Introduction
The skin comprises the epidermal and dermal layers, which together acts as a barrier, protecting the body from physical, chemical and microbial damage. The stratum corneum is the outer layer of the epidermis and comprises keratinocytes and intercellular lipids. The intracellular lipids of the stratum corneum include ceramide, cholesterol, fatty acids and cholesterol esters. These lipids adopt a lamellar structure to perform the barrier function.
Intracellular lipids -ceramide in particular play the most important role in the barrier function of the stratum corneum [1] [2] [3] [4] .
Ceramide species are generated through either the glucosylceramide (GlcCer) pathway or the sphingomyelin (SM) pathway. Generally, ceramides NS and AS are synthesized from sphingomyelin, while all ceramide species are synthesized from glucosylceramide [5, 6] . A lack of various sphingolipids, such as ceramide, or a deficiency of sphingolipid metabolic enzymes can cause diseases including Niemann-Pick disease and Gaucher's disease [7, 8] .
Here we focus on the precursors of ceramide-GlcCer and SM-to elucidate the mechanism controlling increased ceramide levels in the skin. We have previously reported that the application of GlcCer-based liposomes (GlcCer-L) to a three-dimensional cultured human epidermis model (Labcyte Epi-Model) increased ceramide AS content [9] . Moreover, the application of sphingomyelin-based liposomes (SM-L) to a three-dimensional cultured human epidermis model increased levels of ceramides NS, NP, AS and AP [10] . However, why the application of SM-L induced an increase in not only ceramides NS and AS but also ceramides NP and AP in the Labcyte Epi-Model is unknown.
In this study, we prepared SM-L and applied them to a three-dimensional cultured human epidermis model to clarify the influence of SM-L on ceramide metabolic enzymes on threedimensional cultured human epidermis.
Materials and Methods

Cells
LabCyte Epi-Model 6D and culture medium were obtained from Japan Tissue Engineering Co. Ltd. (Gamagori, Aichi, Japan). 
Reagents
Preparation of sphingomyelin-based liposomes (SM-L)
SM-L were prepared using the thin-layer film method and the freezing and thawing method.
Briefly, sphingomyelin was dissolved in chloroform, dried under reduced pressure and the thin-layer film hydrated with PBS. The multi-lamella vesicles were freeze-thawed using liquid nitrogen and then extruded through polycarbonate membrane filters (pore size 100 nm; Nuclepore, Whatman, GE Healthcare Life Sciences, Buckinghamshire, UK). Finally, the SM-L were ultracentrifuged at 4 °C, 230,000 × g for 15 min (himac CS120GX II, Hitachi Ltd., Tokyo, Japan). The liposomal pellets were resuspended in PBS.
Determination of the ceramide class produced by sphingomyelin-based liposomes
Sphingomyelinase (SMase) from Bacillus cereus (1 U) was added to 10 mg/mL of SM-L and incubated at 37 °C for 24 h. Ceramides were developed using high-performance thin layer chromatography (HPTLC). Samples were developed twice with chloroform:methanol:acetic acid (190:9:1 v/v/v). The various ceramides were visualized by treatment with a 10% CuSO 4 , 8% H 3 PO 4 aqueous solution, and heated to 180 °C for 10 min. The amount of ceramide present was quantitatively determined using a densitometer.
Application of SM-L to LabCyte Epi-Model
The three-dimensional cultured human epidermis model was cultured at 37 °C in a 5% CO 2 atmosphere. SM-L (10 or 30 mg/mL) was applied to the stratum corneum side of the three-dimensional cultured human epidermis model followed by incubation at 37 °C for 7 days.
Medium was changed every day (1 mM CBE as an inhibitor of β-glucocerebrosidase (β-GCase) was dissolved in the medium where indicated). After 7 days, the medium containing ascorbic acid was exchanged for enhanced keratinization medium for 24 h.
Lipid extraction
Lipids in the three-dimensional cultured human epidermis model were extracted according to the methods of Bligh and Dyer [11] . Briefly, the skin was dissolved in a chloroform:methanol 
Real-time PCR
SM-L was applied to the stratum corneum side of the three-dimensional cultured human epidermis model followed by a 24 h incubation at 37 °C. Total RNA was then extracted using RNAiso Plus. cDNA was synthesized from total RNA by reverse-transcription using a Prime Script™ reagent kit. Real-time PCR was performed using SYBR Premix Ex Taq™ and the Step One Plus ™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Figure 1 shows the various ceramides isolated from SM-L by HPTLC. Generally, ceramides NS and AS are synthesized from sphingomyelin, while all ceramide species are synthesized from glucosylceramide [5] [6] [7] . After the reaction of SM-L with SMase, ceramide NS was detected, however, the other ceramide classes were not observed. 
Results
Observation of the various ceramide classes produced by sphingomyelin-based liposomes
The ceramide content of the three-dimensional cultured human epidermis model changes following application of SM-L and treatment with β-GCase inhibitor
One mM of the β-GCase inhibitor CBE [15] , with or without 10 mg/mL SM-L, was applied to the stratum corneum side of the three-dimensional cultured human epidermis model for 7 days.
The contents of ceramides NS, NP, AS and AP were all decreased following treatment with CBE (without SM-L; Fig. 3 ). However, ceramide NS was significantly increased (p < 0.05) after treatment with CBE and application of SM-L. The levels of other ceramides were also slightly increased compared with the CBE treatment group, but these increases were not significant).
Figure 3
Discussion
We have previously reported that the application of various sizes of SM-L to a threedimensional cultured skin model can increase the content of ceramides NS, NP, AS and AP [10] .
However, only ceramides NS and AS are synthesized from sphingomyelin [5] . In this study, we prepared SM-L and applied them to the Labcyte Epi-Model to characterize the influence of SM-L on ceramide metabolic enzymes in the three-dimensional cultured human epidermis. First, mixtures of SM-L and Bacillus cereus derived SMase were developed by HPTLC. Only ceramide NS was generated from SM-L (Fig. 1) . Generally, ceramides NS and AS are synthesized from sphingomyelin, while other ceramide species are synthesized from GlcCer [5, 6] . However we have previously reported that application of SM-L to the Labcyte Epi-Model increased levels of ceramides NS, NP, AS and AP. These finding suggest that SM affects not only SMase but also another factor. We next applied SM-L to the Labcyte Epi-Model and measured levels of β-GCase and SMase mRNA expression. Both were increased 24 h after application of 30 mg/mL SM-L (Fig. 2) . This indicates that application of SM-L induced expression of both SMase (a SM metabolic enzyme) and β-GCase (a GlcCer metabolic enzyme).
Finally, we added the β-GCase inhibitor CBE to the medium [16] and applied SM-L to the Labcyte Epi-Model. Ceramides NS, NP and AS contents in the Labcyte Epi-Model were significantly decreased compared with control group following treatment with CBE.
Additionally, ceramide AP content was decreased compared with the control group by treatment with CBE (Fig. 3) . Contrastingly, ceramide NS content was significantly increased following treatment with CBE and SM-L compared with the CBE-alone treatment group. Additionally, other ceramide species were increased compared with the CBE treatment group though these changes were not significant. These findings suggest that SM was metabolized to ceramide NS.
Furthermore, SM may regulate the expression levels of SMase and β-GCase. This suggests that other ceramide species were produced following SM application. Our findings suggest that SMase and β-GCase expression levels were upregulated and ceramide content was subsequently increased following application of SM-L to the three-dimensional cultured skin epidermis model. Therefore, the application of SM-L to skin influences the ceramide metabolism pathway. Ten mg/mL SM-based liposomes were applied to the stratum corneum (SC) side for 7 days.
Data represent means ± SD of three experiments. *p < 0.05, ***p < 0.001, Tukey's test Fig. 3 
